S

Shumway Capital

10 employees

Shumway Capital is a growth focused investment firm that partners with management teams to help accelerate their companies’ growth.

Investor insights

Sectors invested in

Biotechnology9
Medical6
Site development4
Investigator support4
Pharmaceutical4
Patient recruitment4
Health Care4
Study initiation4
Clinical Trials3
Therapeutics3
Machine Learning3
human microbiome and mucosal immunology2
Business Development2
FinTech1
Financial Services1
Finance1
Banking1
Trading Platform1
Electronics1
E-Commerce1

Funding rounds participated in

$43M sweet spot round size

Most of their 11 investments are in rounds between $19M and $68M

Investor type

Family Investment Office

Basic info

Industry

investment management

Date founded

2001

Investments made

E

Elligo Health Research raised $135M on September 24, 2021

Investors: Syneos Health (Previously INC Research/inVentiv Health), Norwest Venture Partners and Shumway Capital

V

Vedanta Biosciences, Inc. raised $68M on July 21, 2021

Investors: Magnetar Capital, JSR Corporation, Skyviews Life Science, PureTech Health and Shumway Capital

F

Finch Therapeutics Group raised $90M on September 17, 2020

Investors: OMX Ventures, Willett Advisors LLC, Trans-Pacific Technology Fund, Octave Ventures LLC, Octave Group, The Baupost Group, Susquehanna International Group (SIG), OCV and Shumway Capital

F

Finch Therapeutics Group raised $54M on August 21, 2019

Investors: Willett Advisors LLC, Trans-Pacific Technology Fund, Susquehanna International Group (SIG), OCV, Avenir Growth Capital and Shumway Capital

V

Vedanta Biosciences, Inc. raised $19M on May 13, 2019

Investors: JSR Corporation, Partners Investment and Shumway Capital

E

Elligo Health Research raised $20M on May 7, 2019

Investors: Excelerate Health Ventures and Shumway Capital

E

Elligo Health Research raised $16M on March 20, 2018

Investors: Excelerate Health Ventures and Shumway Capital

F

Finch Therapeutics Group raised $36M on March 1, 2018

Investors: Willett Advisors LLC, Avenir Growth Capital and Shumway Capital

A

Artsy raised $50M on July 18, 2017

Investors: Thrive Capital, L Catterton and Shumway Capital

E

Elligo Health Research raised undisclosed on March 1, 2016

Investors: Shumway Capital

FAQ